Found: 1
Select item for more details and to access through your institution.
IRIS V-Study: Pioglitazone Reduces High-Sensitivity CRP Values in Patients with Type 2 Diabetes Under Daily Routine Conditions.
- Published in:
- Diabetes, 2007, v. 56, p. A586
- By:
- Publication type:
- Article